FindTrial
Sign In

Evaluation Of Role Of PET-CT In Predicting Lymph Nodal Metastasis In Non-Small Cell Lung Cancer

Evaluation Of Diagnostic Accuracy Of PET-CT In Predicting Lymph Nodal Metastasis In Non-Small Cell Lung Cancer - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103959
Enrollment
138
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Nil: Nil

Sponsors

Department of surgical oncology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with NSCLC planned for upfront surgery Patients with NSCLC planned for surgery after neoadjuvant therapy

Exclusion criteria

Exclusion criteria: Small cell lung cancer. Patient with Dual primary malignancy. Recurrent NSCLC. Patients not consenting for PET-CT or EBUS-TBNA or Surgery

Design outcomes

Primary

MeasureTime frame
To evaluate the diagnostic accuracy of PET-CT in predicting lymph nodal metastasis in non-small cell lung cancer using SUV ratio of Node to Tumor (SUVn/t) in tuberculosis endemic country. Histopathology will be taken as the gold standardTimepoint: At baseline—

Secondary

MeasureTime frame
To determine & compare the sensitivity, specificity, positive predictive value, & negative predictive value of PET-CT parameters SUVmax of mediastinal lymph nodes with SUVn/t.Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Sunil Kumar

AIIMS

dr_sunilk@hotmail.com9968300241

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026